Protocol for the Examination of Specimens from Patients with Non-Hodgkin Lymphoma/Lymphoid Neoplasms



Protocol for the Examination of Specimens from Patients with Non-Hodgkin Lymphoma/Lymphoid Neoplasms













































































































































































Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 13, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Protocol for the Examination of Specimens from Patients with Non-Hodgkin Lymphoma/Lymphoid Neoplasms

Full access? Get Clinical Tree

Get Clinical Tree app for offline access

Non-Hodgkin Lymphoma/Lymphoid Neoplasms: Biopsy, Resection


Surgical Pathology Cancer Case Summary (Checklist)


Specimen (select all that apply)



____ Lymph node(s)



____ Other (specify): ______________________________



____ Not specified


Procedure



____ Biopsy



____ Resection



____ Other (specify): ______________________________



____ Not specified


Tumor Site (select all that apply)



____ Lymph node(s), site not specified



____ Lymph node(s)





Specify site(s): ______________________________



____ Other tissue(s) or organ(s): ______________________________



____ Not specified


Histologic Type



____ Histologic type cannot be assessed



Precursor lymphoid neoplasms




____ B lymphoblastic leukemia/lymphoma, not otherwise specified (NOS)#




____ B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1




____ B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged




____ B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)




____ B lymphoblastic leukemia/lymphoma with hyperdiploidy




____ B lymphoblastic leukemia/lymphoma with hypodiploidy (hypodiploid acute lymphoblastic leukemia/lymphoma [ALL])




____ B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH




____ B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)




____ T lymphoblastic leukemia/lymphoma



Mature B-cell neoplasms




____ B-cell lymphoma, subtype cannot be determined (Note: Not a category within the WHO classification)




____ Chronic lymphocytic leukemia/small lymphocytic lymphoma




____ B-cell prolymphocytic leukemia




____ Splenic B-cell marginal zone lymphoma




____ Hairy cell leukemia




____ Splenic B-cell lymphoma/leukemia, unclassifiable




____ Splenic diffuse red pulp small B-cell lymphoma




____ Hairy cell leukemia-variant




____ Lymphoplasmacytic lymphoma




____ Gamma heavy chain disease




____ Alpha heavy chain disease




____ Plasma cell myeloma




____ Solitary plasmacytoma of bone




____ Extraosseous plasmacytoma




____ Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)




____ Nodal marginal zone lymphoma




____ Pediatric nodal marginal zone lymphoma




____ Follicular lymphoma